Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Single-antigen pertussis vaccine approved by FDA

Aug. 10, 1998

Potassium channel-blocking immunosuppressants from Merck & Co.

July 29, 1998

Novavax extends option agreement with Cantab

July 29, 1998

Scientists report success in achieving tolerance in transplantation models

July 22, 1998

Lisofylline development timetable readjusted, marketing agreements revised

July 22, 1998

Promising phase II results reported for BTI-322 in GVHD

July 21, 1998

Ribi acquires new adjuvant technology from U of Nebraska

July 21, 1998

Human vaccination study demonstrates potential of oral and nasal MaxVax

July 20, 1998

Promising immunosuppressive activity reported for KF-20444

July 17, 1998

In vitro and in vivo studies with VX-497 reported at transplant congress

July 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...